FDA Warning Letters about Products (1987)
The U.S. Food and Drug Administration (FDA) regulates the labeling and sale of foods, drugs, cosmetics, biologicals, and medical devices in interstate commerce. A warning letter is a serious notice to that a marketer appears to be violating federal law and may be subject to enforcement action if the apparent violation continues. Enforcement actions include seizure of goods, injunctions, criminal prosecutions, fines, and imprisonment.
Most sellers do what the FDA requests. In some cases, the product must be removed from the marketplace. In others, marketing can continue as long as the claims to which the FDA objected are stopped. Regardless of the outcome, it is wise for consumers to assume that the product is problematic and should be avoided.
- Bio-Botanica Inc / Josephine Perricone (6/11/87): Nature's Answer Homeopathic Herpes Cream
- Consolidated Research and Technologies, Inc. dba Esion Corporation / Howard Roy Curtin (6/18/87): Interro device, Accupath 1000, Vi-Tel 618
- Modern Pharmacy / Namir Kim (12/22/87): Heart Tonic, Gastrointestinal Pills, Niaiogan Silver, Tian Ma Hu Ku,
Pien, Peking Jen Tang, Po Chai Pills. Euberin, We Chung San Fine Granules, Ryukaku - San Powder Expectorant, Pien Tze Huang.
- Nature-All Formulas / Gary A. Barnes (6/2/87): Colostrum Tablets
- Nature's Bounty / Arthur Rudolph (2/26/87): Ener-B
- Nutrition Headquarters / Henry K. Rosenberger (7/30/87): Atherex
- The Key Company / Wynslow E. Ohlsen (12/22/87): CAL-K, Calcium Orotate, Magnesium Orotate, Zinc Orotate, Potassium Orotate
This page was posted on February 11, 2019.